Literature DB >> 33836152

Oncogenic extrachromosomal DNA functions as mobile enhancers to globally amplify chromosomal transcription.

Yanfen Zhu1, Amit D Gujar1, Chee-Hong Wong1, Harianto Tjong1, Chew Yee Ngan1, Liang Gong1, Yi-An Chen1, Hoon Kim1, Jihe Liu1, Meihong Li1, Adam Mil-Homens1, Rahul Maurya1, Chris Kuhlberg1, Fanyue Sun1, Eunhee Yi1, Ana C deCarvalho2, Yijun Ruan1, Roel G W Verhaak3, Chia-Lin Wei4.   

Abstract

Extrachromosomal, circular DNA (ecDNA) is emerging as a prevalent yet less characterized oncogenic alteration in cancer genomes. We leverage ChIA-PET and ChIA-Drop chromatin interaction assays to characterize genome-wide ecDNA-mediated chromatin contacts that impact transcriptional programs in cancers. ecDNAs in glioblastoma patient-derived neurosphere and prostate cancer cell cultures are marked by widespread intra-ecDNA and genome-wide chromosomal interactions. ecDNA-chromatin contact foci are characterized by broad and high-level H3K27ac signals converging predominantly on chromosomal genes of increased expression levels. Prostate cancer cells harboring synthetic ecDNA circles composed of characterized enhancers result in the genome-wide activation of chromosomal gene transcription. Deciphering the chromosomal targets of ecDNAs at single-molecule resolution reveals an association with actively expressed oncogenes spatially clustered within ecDNA-directed interaction networks. Our results suggest that ecDNA can function as mobile transcriptional enhancers to promote tumor progression and manifest a potential synthetic aneuploidy mechanism of transcription control in cancer.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ChIA-Drop; ChIA-PET; chromatin interactions; ecDNA; mobile enhancers

Mesh:

Substances:

Year:  2021        PMID: 33836152      PMCID: PMC8119378          DOI: 10.1016/j.ccell.2021.03.006

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  52 in total

1.  Chromosomes of human cancer cells.

Authors:  A I SPRIGGS; M M BODDINGTON; C M CLARKE
Journal:  Br Med J       Date:  1962-12-01

2.  A statistical model of ChIA-PET data for accurate detection of chromatin 3D interactions.

Authors:  Jonas Paulsen; Einar A Rødland; Lars Holden; Marit Holden; Eivind Hovig
Journal:  Nucleic Acids Res       Date:  2014-08-11       Impact factor: 16.971

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype.

Authors:  Daehwan Kim; Joseph M Paggi; Chanhee Park; Christopher Bennett; Steven L Salzberg
Journal:  Nat Biotechnol       Date:  2019-08-02       Impact factor: 54.908

5.  A three-dimensional model of the yeast genome.

Authors:  Zhijun Duan; Mirela Andronescu; Kevin Schutz; Sean McIlwain; Yoo Jung Kim; Choli Lee; Jay Shendure; Stanley Fields; C Anthony Blau; William S Noble
Journal:  Nature       Date:  2010-05-02       Impact factor: 49.962

6.  Exploring the landscape of focal amplifications in cancer using AmpliconArchitect.

Authors:  Viraj Deshpande; Jens Luebeck; Nam-Phuong D Nguyen; Mehrdad Bakhtiari; Kristen M Turner; Richard Schwab; Hannah Carter; Paul S Mischel; Vineet Bafna
Journal:  Nat Commun       Date:  2019-01-23       Impact factor: 17.694

7.  PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools.

Authors:  Huaiyu Mi; Anushya Muruganujan; Dustin Ebert; Xiaosong Huang; Paul D Thomas
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

8.  Integrative detection and analysis of structural variation in cancer genomes.

Authors:  Jesse R Dixon; Jie Xu; Vishnu Dileep; Ye Zhan; Fan Song; Victoria T Le; Galip Gürkan Yardımcı; Abhijit Chakraborty; Darrin V Bann; Yanli Wang; Royden Clark; Lijun Zhang; Hongbo Yang; Tingting Liu; Sriranga Iyyanki; Lin An; Christopher Pool; Takayo Sasaki; Juan Carlos Rivera-Mulia; Hakan Ozadam; Bryan R Lajoie; Rajinder Kaul; Michael Buckley; Kristen Lee; Morgan Diegel; Dubravka Pezic; Christina Ernst; Suzana Hadjur; Duncan T Odom; John A Stamatoyannopoulos; James R Broach; Ross C Hardison; Ferhat Ay; William Stafford Noble; Job Dekker; David M Gilbert; Feng Yue
Journal:  Nat Genet       Date:  2018-09-10       Impact factor: 38.330

Review 9.  Common fragile sites: genomic hotspots of DNA damage and carcinogenesis.

Authors:  Ke Ma; Li Qiu; Kristin Mrasek; Jun Zhang; Thomas Liehr; Luciana Gonçalves Quintana; Zheng Li
Journal:  Int J Mol Sci       Date:  2012-09-20       Impact factor: 6.208

10.  The Network of Cancer Genes (NCG): a comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens.

Authors:  Dimitra Repana; Joel Nulsen; Lisa Dressler; Michele Bortolomeazzi; Santhilata Kuppili Venkata; Aikaterini Tourna; Anna Yakovleva; Tommaso Palmieri; Francesca D Ciccarelli
Journal:  Genome Biol       Date:  2019-01-03       Impact factor: 13.583

View more
  31 in total

1.  CircleBase: an integrated resource and analysis platform for human eccDNAs.

Authors:  Xiaolu Zhao; Leisheng Shi; Shasha Ruan; Wenjian Bi; Yifan Chen; Lin Chen; Yifan Liu; Mingkun Li; Jie Qiao; Fengbiao Mao
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

2.  MicroDNA levels are dependent on MMEJ, repressed by c-NHEJ pathway, and stimulated by DNA damage.

Authors:  Teressa Paulsen; Pumoli Malapati; Yoshiyuki Shibata; Briana Wilson; Rebeka Eki; Mouadh Benamar; Tarek Abbas; Anindya Dutta
Journal:  Nucleic Acids Res       Date:  2021-11-18       Impact factor: 16.971

Review 3.  Transcriptional enhancers at 40: evolution of a viral DNA element to nuclear architectural structures.

Authors:  Sreejith J Nair; Tom Suter; Susan Wang; Lu Yang; Feng Yang; Michael G Rosenfeld
Journal:  Trends Genet       Date:  2022-07-07       Impact factor: 11.821

Review 4.  Guilt by association: EcDNA as a mobile transactivator in cancer.

Authors:  Yanfen Zhu; Liang Gong; Chia-Lin Wei
Journal:  Trends Cancer       Date:  2022-06-23

Review 5.  Gene regulation on extrachromosomal DNA.

Authors:  King L Hung; Paul S Mischel; Howard Y Chang
Journal:  Nat Struct Mol Biol       Date:  2022-08-10       Impact factor: 18.361

Review 6.  Structural variations in cancer and the 3D genome.

Authors:  Frank Dubois; Nikos Sidiropoulos; Joachim Weischenfeldt; Rameen Beroukhim
Journal:  Nat Rev Cancer       Date:  2022-06-28       Impact factor: 69.800

Review 7.  Extrachromosomal DNA amplifications in cancer.

Authors:  Eunhee Yi; Rocío Chamorro González; Anton G Henssen; Roel G W Verhaak
Journal:  Nat Rev Genet       Date:  2022-08-11       Impact factor: 59.581

8.  Extrachromosomal DNA in HPV-Mediated Oropharyngeal Cancer Drives Diverse Oncogene Transcription.

Authors:  John Pang; Nam Nguyen; Jens Luebeck; Vineet Bafna; Joseph Califano; Laurel Ball; Andrey Finegersh; Shuling Ren; Takuya Nakagawa; Mitchell Flagg; Sayed Sadat; Paul S Mischel; Guorong Xu; Kathleen Fisch; Theresa Guo; Gabrielle Cahill; Bharat Panuganti
Journal:  Clin Cancer Res       Date:  2021-09-21       Impact factor: 13.801

Review 9.  Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challenges.

Authors:  Imran Noorani; Paul S Mischel; Charles Swanton
Journal:  Nat Rev Clin Oncol       Date:  2022-09-21       Impact factor: 65.011

Review 10.  Revisiting characteristics of oncogenic extrachromosomal DNA as mobile enhancers on neuroblastoma and glioma cancers.

Authors:  Mohsen Karami Fath; Nastaran Karimfar; Andarz Fazlollahpour Naghibi; Shahriyar Shafa; Melika Ghasemi Shiran; Mehran Ataei; Hossein Dehghanzadeh; Mohsen Nabi Afjadi; Tahereh Ghadiri; Zahra Payandeh; Vahideh Tarhriz
Journal:  Cancer Cell Int       Date:  2022-05-25       Impact factor: 6.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.